高血压评估

Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018 May 15;71(19):e127-248. 摘要

James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20.全文  摘要

Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-104.全文  摘要

National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. Nov 2023 [internet publication].全文

Waguespack DR, Dwyer JP. Assessment of blood pressure: techniques and implications from clinical trials. Adv Chronic Kidney Dis. 2019 Mar;26(2):87-91. 摘要

1. Lip GY. Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited. Hypertension. 2003 Feb;41(2):199-200.全文  摘要

2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018 May 15;71(19):e127-248. 摘要

3. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. 摘要

4. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20.全文  摘要

5. Khera R, Lu Y, Lu J, et al. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. BMJ. 2018 Jul 11;362:k2357.全文  摘要

6. SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015 Nov 26;373(22):2103-16.全文  摘要

7. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-104.全文  摘要

8. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. Nov 2023 [internet publication].全文

9. Carey RM, Calhoun DA, Bakris GL, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018 Nov;72(5):e53-90.全文  摘要

10. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957-80.全文  摘要

11. Martin SS, Aday AW, Almarzooq ZI, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. 2024 Feb 20;149(8):e347-913.全文  摘要

12. Falaschetti E, Mindell J, Knott C, et al. Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet. 2014 May 31;383(9932):1912-9. 摘要

13. Lacruz ME, Kluttig A, Hartwig S, et al. Prevalence and incidence of hypertension in the general adult population: results of the CARLA-cohort study. Medicine (Baltimore). 2015 Jun;94(22):e952.全文  摘要

14. Thomas SJ, Booth JN 3rd, Dai C, et al. Cumulative incidence of hypertension by 55 years of age in blacks and whites: the CARDIA study. J Am Heart Assoc. 2018 Jul 11;7(14).全文  摘要

15. Ogden LG, He J, Lydick E, et al. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension. 2000 Feb;35(2):539-43.全文  摘要

16. D'Anci KE, Tipton K, Hedden-Gross A, et al. Effect of intensive blood pressure lowering on cardiovascular outcomes: a systematic review prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines. Ann Intern Med. 2020 Dec 1;173(11):895-903. 摘要

17. Nadar SK, Tayebjee MH, Meserelli F, et al. Target organ damage in hypertension: pathophysiology and implications for drug therapy. Curr Pharm Des. 2006;12(13):1581-92. 摘要

18. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-13. 摘要

19. Blair SN, Goodyear NN, Gibbons LW, et al. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA. 1984 Jul 27;252(4):487-90. 摘要

20. Gerdts E, Sudano I, Brouwers S, et al. Sex differences in arterial hypertension. Eur Heart J. 2022 Dec 7;43(46):4777-88.全文  摘要

21. Brunström M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med. 2018 Jan 1;178(1):28-36. 摘要

22. Saiz LC, Gorricho J, Garjón J, et al. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev. 2018 Jul 20;(7):CD010315.全文  摘要

23. Arguedas JA, Leiva V, Wright JM. Blood pressure targets in adults with hypertension. Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD004349.全文  摘要

24. Wei LK, Au A, Teh LK, et al. Recent advances in the genetics of hypertension. Adv Exp Med Biol. 2017;956:561-81. 摘要

25. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Eng J Med. 1997 Apr 17;336(16):1117-24.全文  摘要

26. Chobanian AV, Hill M. National Heart, Lung, and Blood Institute workshop on sodium and blood pressure. A critical review of current scientific evidence. Hypertension. 2000 Apr;35(4):858-63.全文  摘要

27. Rust P, Ekmekcioglu C. Impact of salt intake on the pathogenesis and treatment of hypertension. Adv Exp Med Biol. 2017;956:61-84. 摘要

28. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021 May 25;143(21):e984-1010.全文  摘要

29. Bravo EL, Gifford RW Jr. Current concepts. Pheochromocytoma: diagnosis, localization and management. N Engl J Med. 1984 Nov 15;311(20):1298-303. 摘要

30. Carey RM. Diagnosing and managing primary aldosteronism in hypertensive patients: a case-based approach. Curr Cardiol Rep. 2016 Oct;18(10):97. 摘要

31. Hofstetter L, Messerli FH. Hypothyroidism and hypertension: fact or myth? Lancet. 2018 Jan 6;391(10115):29-30.全文  摘要

32. Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Rev Cardiovasc Ther. 2010 Nov;8(11):1559-65. 摘要

33. Berta E, Lengyel I, Halmi S, et al. Hypertension in thyroid disorders. Front Endocrinol (Lausanne). 2019 Jul 17;10:482.全文  摘要

34. Meng F, Ma J, Wang W, et al. Obstructive sleep apnea syndrome is a risk factor of hypertension. Minerva Med. 2016 Oct;107(5):294-9. 摘要

35. National Institute for Health and Care Excellence. Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s. NICE guideline NG202. Aug 2021 [internet publication].全文

36. Mokhlesi B, Masa JF, Brozek JL, et al. Evaluation and Management of Obesity Hypoventilation Syndrome. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019 Aug 1;200(3):e6-e24.全文  摘要

37. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021 Jul 20;144(3):e56-67.全文  摘要

38. Tomson J, Lip GY. Alcohol and hypertension; an old relationship revisited. Alcohol Alcohol. 2006 Jan-Feb;41(1):3-4.全文  摘要

39. Vitarello JA, Fitzgerald CJ, Cluett JL, et al. Prevalence of medications that may raise blood pressure among adults with hypertension in the United States. JAMA Intern Med. 2022 Jan 1;182(1):90-3.全文  摘要

40. Dobbin SJH, Cameron AC, Petrie MC, et al. Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors. Heart. 2018 Dec;104(24):1995-2002. 摘要

41. Cohen JB, Lotito MJ, Trivedi UK, et al. Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis. Ann Intern Med. 2019 Jun 18;170(12):853-62.全文  摘要

42. Elliot WJ. Clinical features and management of selected hypertensive emergencies. J Clin Hypertens (Greenwich). 2004 Oct;6(10):587-92. 摘要

43. Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England. J Hypertens. 1994 Nov;12(11):1297-305. 摘要

44. van den Born BJ, Koopmans RP, Groeneveld JO, et al. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens. 2006 Nov;24(11):2299-304. 摘要

45. Waguespack DR, Dwyer JP. Assessment of blood pressure: techniques and implications from clinical trials. Adv Chronic Kidney Dis. 2019 Mar;26(2):87-91. 摘要

46. Gelfer M, Dawes M, Kaczorowski J, et al. Diagnosing hypertension: evidence supporting the 2015 recommendations of the Canadian Hypertension Education Program. Can Fam Physician. 2015 Nov;61(11):957-61.全文  摘要

47. Clark CE, Taylor RS, Shore AC, et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012 Mar 10;379(9819):905-14. 摘要

48. Roerecke M, Kaczorowski J, Myers MG. Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: a systematic review and meta-analysis. JAMA Intern Med. 2019 Mar 1;179(3):351-62.全文  摘要

49. Boonyasai RT, McCannon EL, Landavaso JE. Automated office-based blood pressure measurement: an overview and guidance for implementation in primary care. Curr Hypertens Rep. 2019 Apr 4;21(4):29.全文  摘要

50. Cloutier L, Daskalopoulou SS, Padwal RS, et al. A new algorithm for the diagnosis of hypertension in Canada. Can J Cardiol. 2015 May;31(5):620-30.全文  摘要

51. Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens. 2011 Feb;24(2):123-34. 摘要

52. Parati G, Stergiou GS, Asmar R, et al; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010 Dec;24(12):779-85. 摘要

53. Agarwal R, Bills JE, Hecht TJ, et al. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011 Jan;57(1):29-38. 摘要

54. Stergiou GS, Palatini P, Parati G, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021 Jul 1;39(7):1293-302.全文  摘要

55. Hodgkinson J, Mant J, Martin U, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011 Jun 24;342:d3621.全文  摘要

56. U.S. Preventive Services Task Force. Hypertension in adults: screening. April 2021 [internet publication].全文

57. Cuspidi C, Vaccarella A, Negri F, et al. Resistant hypertension and left ventricular hypertrophy: an overview. J Am Soc Hypertens. 2010 Nov-Dec;4(6):319-24. 摘要

58. Nadar S, Lip GY, Beevers DG. Primary hyperaldosteronism. Ann Clin Biochem. 2003 Sep;40(pt 5):439-52. 摘要

59. Rossi GP, Sacchetto A, Chiesura-Corona M, et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab. 2001 Mar;86(3):1083-90. 摘要

60. Textor SC. Renovascular hypertension in 2007: where are we now? Curr Cardiol Rep. 2007 Nov;9(6):453-61. 摘要

61. Working Group on Renovascular Hypertension. Detection, evaluation, and treatment of renovascular hypertension. Final report. Arch Intern Med. 1987 May;147(5):820-9. 摘要

62. Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-75.全文  摘要

63. Brueck M, Janka R, Daniel WG. Coarctation of the aorta. Circulation. 2001 Feb 13;103(6):E27.全文  摘要

64. Nguyen AT, Baltzan MA, Small D, et al. Clinical reproducibility of the Epworth Sleepiness Scale. J Clin Sleep Med. 2006 Apr 15;2(2):170-4.全文  摘要

65. Rosenthal LD, Dolan DC. The Epworth sleepiness scale in the identification of obstructive sleep apnea. J Nerv Ment Dis. 2008 May;196(5):429-31.全文  摘要

66. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. 摘要

67. Gibson GJ. Obstructive sleep apnoea syndrome: underestimated and undertreated. Br Med Bull. 2005 Mar 29:72:49-65.全文  摘要

68. American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events. Feb 2023 [internet publication].​全文

69. Erratum: evaluation and management of obesity hypoventilation syndrome. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Nov 15;200(10):1326.全文  摘要

70. Mokhlesi B, Tulaimat A, Faibussowitsch I, et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007 Jun;11(2):117-24. 摘要

71. Sivam S, Yee B, Wong K, et al. Obesity hypoventilation syndrome: early detection of nocturnal-only hypercapnia in an obese population. J Clin Sleep Med. 2018 Sep 15;14(9):1477-84.全文  摘要

72. . Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020 Jun;135(6):e237-60. 摘要

73. Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018 Jul;13:291-310. 摘要

74. National Institute for Health and Care Excellence. PLGF-based testing to help diagnose suspected preterm pre-eclampsia. Jul 2022 [internet publication].全文

75. Duhig KE, Myers J, Seed PT, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 2019 May 4;393(10183):1807-18.全文  摘要

76. National Institute for Health and Care Excellence. ​Hypertension in pregnancy: diagnosis and management. Apr 2023 [internet publication].全文

77. Radbill B, Murphy B, LeRoith D. Rationale and strategies for early detection and management of diabetic kidney disease. Mayo Clin Proc. 2008 Dec;83(12):1373-81. 摘要

78. Adler JT, Meyer-Rochow GY, Chen H, et al. Pheochromocytoma: current approaches and future directions. Oncologist. 2008 Jul;13(7):779-93. 摘要

79. Kudva YC, Sawka AM, Young WF Jr. Clinical review 164. The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003 Oct;88(10):4533-9. 摘要

80. Laragh JH. Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int. 1993 Nov;44(5):1163-75. 摘要